0001596771-18-000017.txt : 20180130 0001596771-18-000017.hdr.sgml : 20180130 20180130171207 ACCESSION NUMBER: 0001596771-18-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180129 FILED AS OF DATE: 20180130 DATE AS OF CHANGE: 20180130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SASSINE ANDY CENTRAL INDEX KEY: 0001515322 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 18560002 MAIL ADDRESS: STREET 1: 82 DEVONSHIRE STREET CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gemphire Therapeutics Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 BUSINESS PHONE: 248-980-6538 MAIL ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-01-29 0 0001638287 Gemphire Therapeutics Inc. GEMP 0001515322 SASSINE ANDY 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 1 0 0 0 Stock Option (right to buy) 10.44 2018-01-29 4 A 0 10800 0 A 2028-01-28 Common Stock 10800 10800 D The option vests in a series of 12 successive equal monthly installments on the last day of each month, commencing on the grant date. /s/ Stephanie Swan, by Power of Attorney 2018-01-30